General Surgery Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Department of Biotechnology and Bioscience, University of Milano Bicocca, 20126 Milano, Italy.
Cells. 2021 Feb 25;10(3):497. doi: 10.3390/cells10030497.
The first-line chemotherapies for patients with unresectable pancreatic cancer (PC) are 5-fluorouracil (5-FU) and gemcitabine therapy. However, due to chemoresistance the prognosis of patients with PC has not been significantly improved. Mitochondria are essential organelles in eukaryotes that evolved from aerobic bacteria. In recent years, many studies have shown that mitochondria play important roles in tumorigenesis and may act as chemotherapeutic targets in PC. In addition, according to recent studies, mitochondria may play important roles in the chemoresistance of PC by affecting apoptosis, metabolism, mtDNA metabolism, and mitochondrial dynamics. Interfering with some of these factors in mitochondria may improve the sensitivity of PC cells to chemotherapeutic agents, such as gemcitabine, making mitochondria promising targets for overcoming chemoresistance in PC.
对于不可切除的胰腺癌 (PC) 患者,一线化疗药物为氟尿嘧啶 (5-FU) 和吉西他滨。然而,由于化疗耐药,PC 患者的预后并未得到显著改善。线粒体是真核生物中必不可少的细胞器,它是由需氧细菌进化而来的。近年来,许多研究表明,线粒体在肿瘤发生中发挥着重要作用,并且可能成为 PC 中的化疗靶点。此外,根据最近的研究,线粒体可能通过影响细胞凋亡、代谢、mtDNA 代谢和线粒体动力学来在 PC 的化疗耐药中发挥重要作用。干扰线粒体中的某些因素可能会提高 PC 细胞对化疗药物(如吉西他滨)的敏感性,使线粒体成为克服 PC 化疗耐药的有前途的靶点。